These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 2656626)
1. Comparative evaluation of safety and efficacy of cefmetazole and cefoxitin in lower respiratory tract infections. Yangco BG; Kenyon VS; Halkias KD; Toney JF; Chmel H J Antimicrob Chemother; 1989 Apr; 23 Suppl D():39-46. PubMed ID: 2656626 [TBL] [Abstract][Full Text] [Related]
2. A comparison of cefmetazole, and cefoxitin for the treatment of patients hospitalized with acute urinary tract infections. Burke BM; Kessler DL; Cirulli C; Bracken RB J Antimicrob Chemother; 1989 Apr; 23 Suppl D():35-8. PubMed ID: 2722722 [TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy and safety of cefmetazole or cefoxitin in the prevention of postoperative infection following vaginal and abdominal hysterectomy. Roy S; Wilkins J; Galaif E; Azen C J Antimicrob Chemother; 1989 Apr; 23 Suppl D():109-17. PubMed ID: 2656624 [TBL] [Abstract][Full Text] [Related]
4. Cefmetazole versus cefoxitin in prevention of infections after abdominal surgery. Plouffe JF J Antimicrob Chemother; 1989 Apr; 23 Suppl D():85-8. PubMed ID: 2722727 [TBL] [Abstract][Full Text] [Related]
5. Treatment of skin and soft tissue infections: a comparative study of cefmetazole and cefoxitin. Frank E; Phillips SL; Gupta T; Bavishi N; Casey KK J Antimicrob Chemother; 1989 Apr; 23 Suppl D():55-60. PubMed ID: 2722724 [TBL] [Abstract][Full Text] [Related]
7. A randomized prospective study of antibiotic prophylaxis during abdominal surgery. Gaskill HV; Levine BA J Antimicrob Chemother; 1989 Apr; 23 Suppl D():79-83. PubMed ID: 2722726 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic dilemmas in the treatment of pelvic infections. Gall S J Reprod Med; 1990 Nov; 35(11 Suppl):1091-4. PubMed ID: 2277378 [TBL] [Abstract][Full Text] [Related]
9. Prophylaxis in caesarean section with cefmetazole and cefoxitin. Crombleholme WR; Green JR; Ohm-Smith M; DeKay V; Klaisle C; Luft J; Robbie M; Dahrouge D; Sweet RL J Antimicrob Chemother; 1989 Apr; 23 Suppl D():97-104. PubMed ID: 2722729 [TBL] [Abstract][Full Text] [Related]
10. Controlled comparison of cefmetazole with cefoxitin for prophylaxis in elective cholecystectomy. Berne TV; Yellin AE; Appleman MD; Gill MA; Chenella FC; Heseltine PN Surg Gynecol Obstet; 1990 Feb; 170(2):137-40. PubMed ID: 2405523 [TBL] [Abstract][Full Text] [Related]
11. [Effectiveness of cefmetazole in treatment of lower respiratory tract infections]. Strachunskiĭ LS; Ovsiankin AV Antibiot Khimioter; 1995 Jan; 40(1):31-6. PubMed ID: 7605129 [TBL] [Abstract][Full Text] [Related]
12. [Clinical use of cefoxitin in respiratory tract infections]. Niki Y; Yoshida N; Hara H; Soejima R Jpn J Antibiot; 1984 Jan; 37(1):97-103. PubMed ID: 6727034 [TBL] [Abstract][Full Text] [Related]
13. Clinical experience with cefmetazole sodium in the United States: an overview. Griffith DL; Novak E; Greenwald CA; Metzler CM; Paxton LM J Antimicrob Chemother; 1989 Apr; 23 Suppl D():21-33. PubMed ID: 2656625 [TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of cefoxitin in the treatment of respiratory tract and other acute bacterial infections. Weinstein MP; Eickhoff TC Rev Infect Dis; 1979; 1(1):158-64. PubMed ID: 318217 [TBL] [Abstract][Full Text] [Related]
15. [Double-blind comparative clinical evaluation of cefamandole and cefmetazole in the treatment of respiratory tract infections]. Oshima S; Kikuiri T; Murakami T; Ujiie A; Itoh C; Yajima O; Nitta Y; Tango M; Ichishima Y; Ogi M Jpn J Antibiot; 1983 Oct; 36(10):2769-812. PubMed ID: 6371291 [TBL] [Abstract][Full Text] [Related]
16. [Clinical studies of cefoxitin for the treatment of respiratory tract infections (author's transl)]. Suetsugu S; Naito T; Ishikawa H; Umeda H; Suzuki K; Morise M; Sakai S; Shimokata K; Katayama T; Kobayashi T; Tsunekawa H; Nishimura M; Iwakura M; Nishiwaki K; Nomura Y; Yoshikawa K; Fujii K; Izumi S; Katoh T; Ito T; Hattori J; Yoshii S; Takeura S; Maeda F Jpn J Antibiot; 1982 Feb; 35(2):375-93. PubMed ID: 7087175 [TBL] [Abstract][Full Text] [Related]
17. [Clinical evaluation of cefoxitin in respiratory tract infections]. Kato M; Takeuchi T; Ito M; Nanjo K; Kato J; Yamamoto T; Suzuki M; Kitaura S; Yoshitomo K; Yamamoto M Kansenshogaku Zasshi; 1983 May; 57(5):419-40. PubMed ID: 6413618 [No Abstract] [Full Text] [Related]
18. [Effects of cefoxitin in the treatment of severe infections in patients with hematopoietic disorders]. Hasegawa H; Horiuchi A; Nagai K; Kanamaru A; Masaoka T; Shibata H; Kitani T; Tsubakio T; Kawagoe H; Shinohara Y; Nasu T Jpn J Antibiot; 1982 May; 35(5):1212-22. PubMed ID: 6752459 [TBL] [Abstract][Full Text] [Related]
19. Clinical comparison of piperacillin and cefoxitin in patients with bacteriologically confirmed infections. McCloskey RV Antimicrob Agents Chemother; 1986 Sep; 30(3):354-8. PubMed ID: 3535661 [TBL] [Abstract][Full Text] [Related]
20. [Clinical studies on cefoxitin in the treatment of respiratory tract infections]. Kuwabara M; Kodomari Y; Jyo T; Kuraoka T; Mitsuyama T; Kodomari N; Iwamoto K; Miyazawa T; Watanabe T; Morikawa E Jpn J Antibiot; 1984 Sep; 37(9):1685-93. PubMed ID: 6512985 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]